Rachel Fox
Markets Reporter, Financial Content at Investor's Business Daily
Writer at @IBDinvestors
Articles
-
1 week ago |
investors.com | Rachel Fox
One of the top medical product makers to watch is Boston Scientific (BSX), whose stock has formed a first-stage consolidation. While shares are not yet actionable, the stock deserves a spot on investors' watchlists as it attempts to retake support. First-stage bases tend to be a feature, rather than a bug. Investors can tell the age of a stock's advance…
-
1 week ago |
investors.com | Rachel Fox
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning.
-
3 weeks ago |
investors.com | Rachel Fox
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning.
-
1 month ago |
investors.com | Rachel Fox
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning.
-
1 month ago |
investors.com | Rachel Fox
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 18K
- Tweets
- 8K
- DMs Open
- No
Recently, we've seen some seriously volatile moves in growth stocks compared with their average true range. Check out today's IBD Live clip for more on how ATR can help you better manage risk. @mwebster1971 https://t.co/PMR34FSTyu
https://t.co/Ifo7fgyORC Earnings events can throw a wrench in your plans to buy the perfect breakout stock. In this video, IBD's Chris Gessel explains a hedging strategy that changes the game in terms of how close investors can buy stocks ahead of earnings.
Big events like Fed decisions, elections and earnings reports can cause serious stock market volatility. Here’s the game plan for how to keep your portfolio safe in uncertain times. https://t.co/c86AbsiV6d